Opendata, web and dolomites

CAPSULTEK SIGNED

Unlocking the potential of thermo-sensitive bioactive ingredients through a disruptive encapsulation method

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CAPSULTEK project word cloud

Explore the words cloud of the CAPSULTEK project. It provides you a very rough idea of what is the project "CAPSULTEK" about.

besides    line    formulation    stability    scalable    functional    bioavailability    business    basic    concentration    nanoencapsulation    moment    health    damaging    claim    molecule    optimize    prototype    assuring    foresee    assisted    model    wise    industry    food    fifth    ph    probiotics    grow    massively    innovative    industrially    2022    vulnerable    integrity    bold    volumes    gas    easily    experts    encapsulation    foods    entail    matrix    industrial    acceptance    usually    nutritional    lasting    added    adding    living    omega    eager    oxidation    protect    megatrend    intensive    consumers    introducing    launched    bioactive    bioinicia    deploying    prone    markets    market    portfolio    vitamins    50    benefits    global    encapsulated    stated    industries    started    additional    commercialization    profit    temperature    shelf    capsultek    reduce    demo    until    life    extend    room    companies    revenue    first    electrospraying    thermolabile    energy    plant    40    encapsulate    ingredients    readiness    certain    pressurized    designed   

Project "CAPSULTEK" data sheet

The following table provides information about the project.

Coordinator
BIOINICIA SL 

Organization address
address: CALLE ALGEPSER 65 PUERTA 3
city: PATERNA
postcode: 46980
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 985˙062 €
 EC max contribution 689˙543 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2021-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOINICIA SL ES (PATERNA) coordinator 689˙543.00

Map

 Project objective

Functional foods provide additional health benefits beyond its nutritional value by adding certain bioactive ingredients to its basic formulation, like Omega-3, probiotics or vitamins. They are massively consumed, being a long-lasting megatrend in food industry, started in the 80’s, and currently living its best moment. Their generated revenue will grow by 50 % until 2022. 1 out of 4 new food products launched have a functional claim. So, global food industries are eager to increase their functional food products portfolio due to its high consumers’ acceptance, potential for deploying new markets, and higher added value. However, most of these bioactive ingredients are easily vulnerable (prone to oxidation, thermolabile…), so, there is a challenge in assuring their integrity and bioavailability when introducing them in food products (complex matrix!). To protect them they are usually encapsulated. Most encapsulation methods work at high temperature damaging the ingredients. Moreover, most methods are energy-intensive, and entail high production costs. In Bioinicia we are experts in nanoencapsulation, and we have developed CAPSULTEK: an innovative own-developed technology called Electrospraying Assisted by Pressurized Gas of which we have a 1 t/year prototype. With our technology we can work at room temperature, encapsulate any kind of molecule, enhance its stability and extend its shelf-life. Besides, industrially-wise, we can scale it up to reach industrial volumes, to reduce encapsulation costs by 40% and to increase concentration bioactive ingredients by 50%. We need Ph.2 to reach market readiness. We will build an industrial demo plant of 10 tonnes/year and will optimize the processing parameters for Omega-3 and probiotics. We have designed a bold and effective highly scalable business model to make the most of CAPSULTEK. First-line food companies have already stated their interest on it, and we foresee an 8 M€ profit by the fifth year of its commercialization.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CAPSULTEK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CAPSULTEK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

MindTrack (2019)

Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders

Read More